HAP Trading’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

HAP Trading’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,400	Closed	-$5K	–	3024
2021 Q3	$5K	Buy	+11,400	New	+$315K	﹤0.01%	2193

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

HAP Trading's DRNA Position: Q4 2021 in Review

HAP Trading sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 16,352 shares — an estimated $330K sold.

HAP Trading first reported a position in DRNA in Q3 2021 and held it in 1 quarter. The position peaked at $330K in Q3 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

HAP Trading reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
HAP Trading sold 16,352 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $330K.
HAP Trading first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2021 and held it in 1 quarter.
HAP Trading's Dicerna Pharmaceuticals, Inc. position peaked at $330K in Q3 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.